Regulus Therapeutics
Regulus Therapeutics
Employees:
80
Market Cap:
$38.03 million
Revenue:
$72 thousand
5 Year Trend:
64.4%
Net Income:
$-71.28 million
Stock:
RGLS

Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a biopharmaceutical company focused on the development of microRNA-based drugs targeting fibrosis, metabolism and cardiovascular diseases, cancer, HCV and immune-related diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia

Regulus Therapeutics
Are you from Regulus Therapeutics?

Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a biopharmaceutical company focused on the development of microRNA-based drugs targeting fibrosis, metabolism and cardiovascular diseases, cancer, HCV and immune-related diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia

Employees:
80
Market Cap:
$38.03 million
Revenue:
$72 thousand
5 Year Trend:
64.4%
Net Income:
$-71.28 million
Stock:
RGLS

Jobs at Regulus Therapeutics

There are no jobs at the current time